CLLS

NASDAQ · Equity

Cellectis SA

US Healthcare Biotechnology

Latest week
29 May 2026
Close
3.520000
Fair value
2.546608
Expectation
Negative 42.97%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
3.52
12-Week Change
2.92%
Trend Signal
Inactive
Expectation
Negative 42.97%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-14.82
Market Dynamics
-0.03

Over the latest 12 completed weeks ending 2026-05-29, CLLS rose 2.92%, moving from 3.42 to 3.52. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -14.82 and has softened across the 12-week window. Market Dynamics is -0.03 on the latest week. Expectation is negative at 42.97%.